Avalo Therapeutics Inc
(AVTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2013 | 12-2006 | |
| Operating Expenses | 17,116 | 12,935 | 0 |
| Operating Income | -17,116 | -12,935 | N/A |
| Other Income | 1,060 | -111 | 0 |
| Pre-tax Income | -16,056 | -13,045 | 0 |
| Net Income Continuous | -16,056 | -13,045 | N/A |
| Net Income | $-16,056 | $-13,045 | $N/A |
| EPS Basic Total Ops | -15,663.41 | -59,223.69 | N/A |
| EPS Basic Continuous Ops | -71,476.25 | -58,842.03 | N/A |
| EPS Diluted Total Ops | -15,663.41 | -59,223.69 | N/A |
| EPS Diluted Continuous Ops | -71,476.25 | -58,842.03 | N/A |
| EBITDA(a) | $-17,087 | $-12,914 | $N/A |